G. Deeb

4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial.

P. Teirstein, H. Gada, B. Ramlawi, 2023, Journal of the American College of Cardiology.

Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.

B. Kiaii, N. Van Mieghem, H. Gada, 2024, JACC. Cardiovascular interventions.

Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement.

D. Adams, J. Afilalo, G. Deeb, 2016, Journal of the American College of Cardiology.

Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis.

N. Van Mieghem, S. Chetcuti, William M. Merhi, 2024, JACC. Cardiovascular interventions.

Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus.

B. Whisenant, H. Gada, B. Ramlawi, 2024, The New England journal of medicine.

3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.

J. Kauten, H. Gada, S. Chetcuti, 2024, JACC. Cardiovascular interventions.